(Q53754804)

English

Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Barrett's esophagus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Gareth J Jenkins

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Elizabeth McAdam

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Antonios Danikas

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chris Tselepis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paul Griffiths

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

John Baxter

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Linzi Thomas

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

James Manson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

14 December 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

46-56

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21157443%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

The HER family and cancer: emerging molecular mechanisms and therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Tumor marker expression is predictive of survival in patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Cost effectiveness of detecting Barrett's cancer

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Epidermal growth factor receptor-directed therapy in esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Amplification and over-expression of theEGFR anderbB-2 genes in human esophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.433

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53754804&oldid=1410462332"